Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11952597 Compositions and methods relating to a mutant

Patent 11952597 was granted and assigned to Pfizer on April, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Annaliesa Sybil Anderson0

Mark Edward Ruppen0

Jason Arnold Lotvin0

Maninder K. Sidhu0

Robert G. K. Donald0

Weiqiang Sun0

Kathrin Ute Jansen0

Narender Kumar Kalyan0

...

Date of Patent

April 9, 2024

0

Patent Application Number

169229520

Date Filed

July 7, 2020

0

Patent Citations

US Patent 7625559 Antibodies against

0

US Patent 7750204 Methods for producing antibody

0

US Patent 8420352 Protein delivery system to generate pluripotent stem (iPS) cells or tissue specific cells

0

US Patent 8444996 Multicomponent vaccine for malaria providing long-lasting immune responses against plasmodia

0

US Patent 8481692 Compositions relating to a mutant

0

US Patent 6939548 Methods to produce high levels of C. difficile toxins

0

US Patent 6969520 Active immunization against clostridium difficile disease

0

US Patent 7037503 Compounds and methods for the treatment and prevention of bacterial infection

0

...

Patent Primary Examiner

0

CPC Code

0

0

0

Patent abstract

In one aspect, the invention relates to an immunogenic composition that includes a mutant

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11952597 Compositions and methods relating to a mutant

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool